CN105777606A - Synthesis method of medicine intermediate 1-tert-butyloxycarboryl-2-cyanopyrrolidone - Google Patents

Synthesis method of medicine intermediate 1-tert-butyloxycarboryl-2-cyanopyrrolidone Download PDF

Info

Publication number
CN105777606A
CN105777606A CN201410793597.XA CN201410793597A CN105777606A CN 105777606 A CN105777606 A CN 105777606A CN 201410793597 A CN201410793597 A CN 201410793597A CN 105777606 A CN105777606 A CN 105777606A
Authority
CN
China
Prior art keywords
cyanopyrrolidone
butyloxycarboryl
tert
medicine intermediate
pyrrolidone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410793597.XA
Other languages
Chinese (zh)
Inventor
彭海燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WUXI QIANHAO BIO-PHARMACEUTICAL Co Ltd
Original Assignee
WUXI QIANHAO BIO-PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WUXI QIANHAO BIO-PHARMACEUTICAL Co Ltd filed Critical WUXI QIANHAO BIO-PHARMACEUTICAL Co Ltd
Priority to CN201410793597.XA priority Critical patent/CN105777606A/en
Publication of CN105777606A publication Critical patent/CN105777606A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pyrrole Compounds (AREA)

Abstract

The invention relates to a synthesis method of a medicine intermediate 1-tert-butyloxycarboryl-2-cyanopyrrolidone. The method comprises the following steps: ammonifying a raw material pyrrolidone and butanolide at 100-120DEG C under 1atm under the action of acetone, and carrying out a cyanidation reaction to generate 1-tert-butyloxycarboryl-2-cyanopyrrolidone. The synthesis method of the medicine intermediate 1-tert-butyloxycarboryl-2-cyanopyrrolidone has the advantages of simplicity, high efficiency, safe operation, and high practicality in concrete production.

Description

The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-2-cyano pyrrolidone
Technical field
The present invention relates to the synthetic method of a kind of medicine intermediate 1-tertbutyloxycarbonyl-2-cyano pyrrolidone.
Background technology
1-tertbutyloxycarbonyl-2-cyano pyrrolidone is the initiation material of many pharmaceutical synthesis, particularly the important intermediate of a lot of pyrrolidone-2 compounds, at present the domestic synthetic method having no this compound of report.
Summary of the invention
It is an object of the invention to overcome above-mentioned deficiency, it is provided that a kind of simple, efficiently, the synthetic method of the medicine intermediate 1-tertbutyloxycarbonyl-2-cyano pyrrolidone of safety operation.
The object of the present invention is achieved like this:
A kind of synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-2-cyano pyrrolidone, with ketopyrrolidine for raw material, under 1 atmospheric pressure and solvent acetone effect, first and butyrolactone ammonification at temperature 100 DEG C-120 DEG C, then pass through cyaniding and generate 1-tertbutyloxycarbonyl-2-cyano pyrrolidone.
Compared with prior art, the invention has the beneficial effects as follows:
The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-2-cyano pyrrolidone of the present invention is simple, efficient, and operates safety, very useful in concrete production.
Detailed description of the invention
The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-2-cyano pyrrolidone of the present invention is specific as follows:
With ketopyrrolidine for raw material, under 1 atmospheric pressure and solvent acetone effect, first and butyrolactone ammonification at temperature 100 DEG C-120 DEG C, then pass through cyaniding and generate 1-tertbutyloxycarbonyl-2-cyano pyrrolidone.The purity of this crude product can meet general reaction requirement, can direct plunge in reaction.

Claims (1)

1. the synthetic method of a medicine intermediate 1-tertbutyloxycarbonyl-2-cyano pyrrolidone, it is characterized in that with ketopyrrolidine for raw material, under 1 atmospheric pressure and solvent acetone effect, first and butyrolactone ammonification at temperature 100 DEG C-120 DEG C, then passes through cyaniding and generates 1-tertbutyloxycarbonyl-2-cyano pyrrolidone.
CN201410793597.XA 2014-12-20 2014-12-20 Synthesis method of medicine intermediate 1-tert-butyloxycarboryl-2-cyanopyrrolidone Pending CN105777606A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410793597.XA CN105777606A (en) 2014-12-20 2014-12-20 Synthesis method of medicine intermediate 1-tert-butyloxycarboryl-2-cyanopyrrolidone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410793597.XA CN105777606A (en) 2014-12-20 2014-12-20 Synthesis method of medicine intermediate 1-tert-butyloxycarboryl-2-cyanopyrrolidone

Publications (1)

Publication Number Publication Date
CN105777606A true CN105777606A (en) 2016-07-20

Family

ID=56384621

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410793597.XA Pending CN105777606A (en) 2014-12-20 2014-12-20 Synthesis method of medicine intermediate 1-tert-butyloxycarboryl-2-cyanopyrrolidone

Country Status (1)

Country Link
CN (1) CN105777606A (en)

Similar Documents

Publication Publication Date Title
CN105777606A (en) Synthesis method of medicine intermediate 1-tert-butyloxycarboryl-2-cyanopyrrolidone
CN106117210A (en) The synthetic method of medicine intermediate hydroxyl 3-hydroxypyrrole pyrimidine
CN106117106A (en) The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-3-ethyl pyrrolidone
CN106117107A (en) The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-4-methyl pyrrolidone
CN106117105A (en) The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-3-hydroxyethyl-pyrrolidone
CN105753771A (en) A synthetic method of a medical intermediate trans-3-N-boc-aminopiperidine
CN105777605A (en) Synthetic method of medicine intermediate 3-hydroxypyrrolidone
CN105777527A (en) Synthesis method of medicine intermediate 3-oxocyclobutanecarboxylic acid
CN106117108A (en) The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-3-methylpyrrole piperidines
CN106146376A (en) The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone
CN106117208A (en) The synthetic method of medicine intermediate 5-ethoxy pyrrolopyrimidine
CN106117209A (en) The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-4-pyrrolopyrimidine
CN106146363A (en) The synthetic method of medical material 3-methyl sulfinic acid amine salt
CN106117103A (en) The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-3-(methoxymethyl-carbamyl) pyrrolidine
CN106146382A (en) The synthetic method of medical material 2-methyl-L-tryptophan
CN106117110A (en) The synthetic method of medical material 3-ethyl-L-Trp
CN105753760A (en) A synthetic method of a medical intermediate N-boc-3-pyrrolidinone
CN106117151A (en) The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-3-(methoxymethyl-carbamyl) piperazine
CN106146377A (en) The synthetic method of medicine intermediate 4-dimethylamino pyrrolidones
CN106146499A (en) The synthetic method of medicine intermediate 5-trifluoroethyl guanine
CN106117102A (en) The synthetic method of medicine intermediate trans 3-t-butoxycarbonyl amino pyrrolidine
CN105777658A (en) Synthesis method of medicine intermediate 1-tert-butyloxycarboryl-2-methylpiperazine
CN106146275A (en) The synthetic method of medical material 2-methyl-3-ethyl cyclohexanone
CN106146273A (en) The synthetic method of medical material 2-ethyl-2-hydroxy-cyclohexanone
CN106117109A (en) The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-2-crassitude

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160720

WD01 Invention patent application deemed withdrawn after publication